Home »
Antipsychotic medications can impairer the body’s ability to regulate its own temperature and hot weather can lead to hyperthermia (heat stroke). Antipsychotic medications are used to treat psychosis in a variety of psychiatric conditions such as schizophrenia, bipolar disorder, major depression, personality disorder, and agitation in dementia. However, some antipsychotics are also used to treat unrelated issues such as persistent […]
Read more
Disease-causing pathogens encounter different host characteristics – age, physiology, nutritional status, and immune response are some basic differences which pathogens confront. However, the most striking contrast which the pathogens encounter is the gender of the host species. Women and men are different in many aspects. The interesting fact is that these differences are also observed in their risk of contracting […]
Read more
The Division of Physician-Scientists at Washington University School of Medicine in St. Louis has selected four physicians for its second class of Dean’s Scholars. The program provides up to two years of financial support and mentorship to aspiring, early-career physician-scientists, along with dedicated time for conducting laboratory research. The newly named class includes: Mary “Maggie” Mullen, MD; Matthew Shew, MD; […]
Read more
Violence against women is a “global public health problem of epidemic proportions, requiring urgent action”, the World Health Organization declared in 2013. Violence against Women. Image Credit: Jacob Lund/Shutterstock.com Unfortunately, sexual and physical violence against women is commonplace across the world. It is a breach of human rights and causes significant long-lasting physical and psychological harm and even death. The […]
Read more
mobocertinib Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE) April 27, 2021– Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New […]
Read more
The safety and versatility of pseudoviruses as virological tools have supported their use in assessing the efficacy and safety of vaccines and therapeutic agents against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2. Image Credit: Kateryna Kon/Shutterstock.com Advantages of a pseudovirus system Pseudoviruses are excellent tools for studying novel and highly pathogenic viruses that would otherwise require laboratory […]
Read more
Dolores B. Njoku, MD, a noted clinician, researcher and mentor, has been named the director of pediatric anesthesiology at Washington University School of Medicine in St. Louis and anesthesiologist-in-chief at St. Louis Children’s Hospital. With the post, she will become the new Rudolph L. and Mary Frances Wise Endowed Chair in Pediatric Anesthesiology. She also has been appointed a vice […]
Read more
Anthony Odibo, MD, an internationally respected maternal-fetal medicine expert, has been named director of the Division of Maternal-Fetal Medicine & Ultrasound in the Department of Obstetrics & Gynecology at Washington University School of Medicine in St. Louis. He also has been appointed vice chair of obstetrics in the department. Odibo previously served as a division director and vice chair in […]
Read more
The Dali Lama is a Tibetan spiritual leader. However, he likes to refer to himself as a simple Buddhist monk. Perhaps, this trait is what makes him quite special. Having been ordained as the new Dalai Lama at a young age, he’s spent almost all of his life dedicated to living the life of a monk. His daily regimen typically […]
Read more
Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia NORTH CHICAGO, Ill., Feb. 25, 2021 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The FDA is expected to act on […]
Read more